genome maintenance systems, cancer and aging · oliver bischof (pasteur inst), shurong huang (u...
TRANSCRIPT
NIH DNA RepairFeb, 2005
Dr. Judy Campisi
Genome maintenance systems, cancer and aging
CancerMajor cause of mortality after about the mid-point of maximum life span
Why does it happen?
Why doesn't it happen more often?
Tumor suppressor mechanisms
curtail the development of
cancer throughout the life span
Two Classes of Tumor Suppressors
• CARETAKERS -- act on the genome
Prevent cancer by preventing mutationsDamage prevention and repair
• GATEKEEPERS -- act on cellsPrevent potential cancer cells from forming tumors
Apoptosis - causes potential cancer cells to dieCellular senescence - prevents their growth
Caretaker tumor suppressors arelongevity assurance genes
(e.g., BLM, WRN, TELOMERES)
Gatekeeper tumor suppressors can beantagonistically pleiotropic
ANTAGONISTIC PLEIOTROPY
(evolutionary hypothesis of aging)
What's good for you when you are young
can be bad for you when you are old.
Why might gatekeeper tumor suppressors --be antagonistically pleiotropic??
APOPTOSIS -- culls defective cells…..but deplete tissues of cells
CELLULAR SENESCENCE -- arrests proliferation of defective cells …..
but senescent cells are dysfunctional
Suppressing cancer costs -- aging
Tumor Suppressor mechanisms
AgingPhenotypes
Care-takers(prevent/
repair damage)
Gate-keepers
(eliminate/arrestdamaged cells)
Apoptosis
Senescence
Deplete proliferating/stem cell pools --->
Tissue atrophy/degeneration
Deplete proliferating/stem poolsCell dysfunction ---> loss oftissue function/homeostasis
Late lifephenotypes,
including cancer(antagonisticpleiotropy)
p53
Bloom Syndrome Werner Syndrome
Life Span = 4-5 decades
Normal until pubertyPremature aging
Cancer prone (mesenchyme)Cardiovascular disease
Type II diabetesCataracts
*
Life Span = 2-3 decades
Small from birthCancer prone (age-type)Sun-sensitive skin rash
Immune-deficientType II diabetesMale infertility
*
Human RECQ-like helicases
helicaseRecQ1
helicase --> BSBLM
--> WSexo helicaseWRN
helicaseRecQ4/RTS
helicaseRecQ5
BLM, WRN -- no obvious tissue-specificity
-- no obvious developmental specificity
What are the unique functions of WRN and BLM that might account for
the unique phenotypes of WS and BS?
BLM PML Merged Dapi
BLM localizes to PML bodies
BLM is expressed in S phase
IP: RAD51 IgG Input (10%)
BLM interacts withRAD51
WB: BLM
WB: RAD51
Role in homologous recombinationG0 G1 G1/S S S S G2
BLM
pro
tein
Bischof et al., J Cell Biol 153: 367 (2001)
BSF/BLM
BLM
BSF/HM
NHF/HM
NHF
MergePML
NHF
DAPI
NHF
NHF + HM
BSF
BSF + B
BSF + HMLM
Isogenic ‘normal’human BS fibroblasts
+/- BLM Tubulin
BLM
‘Normal’ =telomerized
‘Normal’ =p53 checkpoints
intact
Davalos & Campisi, J Cell Biol 162: 1197 (2003)
BS cells are mildly hypersensitive to DNA damaging agents:
APOPTOSIS
Also..Bleomycin, X-rays
% A
POPT
OSI
S (M
ito)
10
30
10 30
Etoposide
Wild-typeBSBS + BLMWild-type + HM-BLM
30 30
Com
plem
enta
tion
Dom
inan
t Neg
10 30
WS
Exponentially growing cells
Damaged BS fibroblasts die by apoptosisNHF BSF + BLMBSF
-
+
HU
0
0.1
0.2
NHF BSF BSF + BLM
untreated
Etoposide
Etoposide +DEVD0.D
. (40
5)
Cells
Hypersensitivity of BS cells confined to S phaseWild-typeBSBS + BLM
Etoposide, 30 uM
G1 S phase S phase
Wild-type + HM-BLM
% A
popt
osis 60
20
% Labeled Nuclei: <5% >80% >80%
Hypersensitivity of BS cells in S phasedue to stalled replication forks
Wild-typeBSBS + BLM
Hydroxyurea
G1 S phase S phase
Wild-type + HM-BLM
% A
popt
osis 60
20
Stalled replication forks develop DSBs;BLM localizes to replication forks with DSBs
Bleomycin HUUntreated
BLM
γ−H2AX
Merge
DAPI
Co-localization: 60-70% >95%
BLM responds rapidly to damagedreplication forks
% C
ells
with
H2A
X fo
ci
100
50
Time (min) after stall5 15 30 60 %
w C
o-lo
caliz
ed B
LM/H
2AX
IgG
- +
α−BLM
- +
HU
Input (10%)
- +
WB: γ-H2AXIP: BLM
Complex with γ-H2AX
BS cells undergo apoptosis at high frequency when replication forks stall
Endogenous oxidative damage continuallystalls replication forks
BS cells are continually faced with conditions that favor cell death
Why are children with BS small?
BS children continually lose cells byapoptosis
(during embryogenesis and throughout life)
APOPTOSIS SUPPRESSES CANCER
Why are children with BS cancer prone(not progeroid)?
≈70% BS cells undergo apoptosis whenreplication forks stall
What happens to the survivors?
Synchronize survivors in S phase
+ HU:
20-30% survival
(Survival is stochastic)
Apoptotic death of BS cells is p53-dependent%
Apo
ptos
is
50
Cont + E6/DN Cont + E6/DN NF BSF
UntreatedHU
p53
NH
F
BSF
+ 1
43
BSF
BSF
+ E
6
Actin
p53 prevents survival of BS cells withdamaged replication forks
(cells at risk for faulty repair)
BS cells are under pressure to lose p53function in order to survive damage
during replication
Loss of p53 function + susceptibility to mutations ---->
very high risk for developing cancer
Children with BS die of cancer before high rate of apoptosis can produce
progeroid symptoms
What is the function of BLM at damagedreplication forks?
What is the role of p53?
Davalos et al., Cell Cycle 3: 1579 (2004)
BLM
PML
Merge
Dapi
NHF BS/BLM
Untreated
BLM moves transiently from PML bodies to replication forks with DSBs
NHF BS/BLM
HU Stall, 1 h
NHF BS/BLM
HU 1 h + 3 h recovery
What regulates BLM movement from PML bodies to damaged replication forks?
ATM, ATR damage signaling kinases?
ATR required for BLM translocation todamaged replication forks
ATR-deficient human Fb (TF) + dox-inducible flag-KD-ATR (dominant negative)Primary NHF, WT or ATR-deficient (Seckle syndrome)
UntreatedATR WT KD
HU, 1 hWT KD
BLM
PML
Merge
Dapi
wt ATR KD ATRDox - - ++
ATR
Actin
PML
ATR Merge
DAPI
PML
ATR Merge
DAPI
WT
ATR
K
D A
TR
ATM required for BLM return to PML bodiesAT human fibroblasts, +/- telomerase
1 hHU 4 h 6 h
BLM
PML
Merge
Dapi
Structural function for BLM atdamaged replication forks ?
BLM required for BRCA1, NBS1 recruitment to damaged replication forks
BRCA1 +/m
BLM PML
Merge DAPI
NBS1 -/-
BLM PML
Merge DAPI
BSF + BLM
NHF
BSF
BRCA1 Dapi NBS1 DAPI
-
+
-
+
-
+
HU
HU - - -+ + +NHF BSF BSF+BLM
BRCA1Actin
BLM
NBS1
Input (10%) IP: IgG IP: BLMHU - + - + - + WB:
Catalytically inactive BLM restores BRCA1, NBSIlocalization to damaged replication forks
BRCA1 DAPI NBS1 HU DAPI
--
NHF
++
--
BSF
++
NBS1 BRCA1 DAPI Merge
--
BSF + HM ++
BLM required for 53BP1 recruitment and ATM activation
BS
F1
Unt
Bleo
HU
ATM S1981 53BP1 Merge N
HF
Unt
Bleo
HU
ATM S1981 53BP1 Merge
- +
53BP1
NHF
- +
BSF/BLM
- +
BSF NHF
HUHU - 1h 4h
ATM S1981ATM S1981
ATM Actin
Actin
Actin
What is the role of p53 in BLM function?
p53 prevents repair complexes from formingin absence of BLM
0
20
40
60
80
100
UntHU
FociP53 status
BRCA1 BRCA1 NBS1 NBS1WT Mut WT Mut
% C
ells
with
foci
NBS1
BRCA1
NHF + E6 + HUBS Cells -- 1 h after stall
HU - + ATM S1981 53BP1 Merge
ATM S1981 BSF+
DN-p53
ATM
Actin
53BP1
Actin
p53 orchestrates assembly of repair complexesat replication forks with DSBs(prevent error-prone repair?)
BLM is crucial for orchestrated,p53-dependent repair complex assembly
BLM + p53 deficiency ---> genomic instability,(cancer)
Werner Syndrome
Life Span = 4-5 decades
Normal until pubertyPremature aging
Cancer prone (mesenchyme)Cardiovascular disease
Type II diabetesCataracts
*
Human RECQ-like helicases
helicaseRecQ1
helicaseBLM
WRN exo helicase
helicaseRecQ4/RTS
helicaseRecQ5
WRN is not cell cycle regulated;Localizes to nucleoli
N le
vel
WR
G0 G1 S G2 M
WRN B23 Merge DAPI
WRN interacts with components of NHEJ
Yannone et al., J Biol Chem 276: 38242 (2001)
WS 5' d
elet
ion
BR
EAK
3' d
elet
ion
WRN deficiency causes extensive 3' deletion at non-homologously joined ends
Oshima et al., Cancer Res 62: 574 (2002)
WS + WRNWild-type
WRN can interact with NHEJ components and participates in NHEJ reactions
NHEJ requires a helicase to search for microhomology and exonuclease to
process broken ends
Cells defective in NHEJ are extremelysensitive to IR
WS cells are mildly IR-sensitive
WS cells are mildly X-ray sensitive
Under what circumstances is the WRN-NHEJ interaction relevant?
Dysfunctional telomeres resemble DNADSBs, substrates for NHEJ
WRN deficiency accelerates senescence(in contrast to BLM deficiency, which increases apoptosis)
(premature accumulation of senescent cells -->loss of tissue function & homeostasis,
promotes late life cancer)
Abrogated by telomerase (epithelial stem cells)
Thanks!
Present Lab members: Albert Davalos,Seok-Jin Heo, Patrick Kaminker, Francis Rodier
Past Lab members: Junko Oshima (UWA)Oliver Bischof (Pasteur Inst),
Shurong Huang (U WA), Sashwati Roy (OSU)
Collaborators: Sandy Chang (MDAnderson),David Chen/Steve Yannone (LBNL),
Nathan Ellis (Sloan-Kettering), Junko Oshima(U WA), Robert Shiestl (UCLA)